Amalgamated Bank Cuts Stake in HealthEquity, Inc. (NASDAQ:HQY)

Amalgamated Bank lessened its stake in HealthEquity, Inc. (NASDAQ:HQY) by 1.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 53,636 shares of the company’s stock after selling 676 shares during the quarter. Amalgamated Bank’s holdings in HealthEquity were worth $3,556,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HQY. Xponance Inc. lifted its stake in HealthEquity by 1.2% in the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock worth $813,000 after purchasing an additional 147 shares in the last quarter. Fifth Third Bancorp boosted its stake in HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after buying an additional 161 shares during the last quarter. HighTower Advisors LLC grew its holdings in HealthEquity by 0.4% during the 3rd quarter. HighTower Advisors LLC now owns 86,940 shares of the company’s stock valued at $6,366,000 after buying an additional 340 shares in the last quarter. Mariner LLC raised its holdings in shares of HealthEquity by 2.4% during the 3rd quarter. Mariner LLC now owns 14,983 shares of the company’s stock worth $1,095,000 after acquiring an additional 345 shares in the last quarter. Finally, McGlone Suttner Wealth Management Inc. bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $29,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 0.7 %

NASDAQ:HQY opened at $77.45 on Friday. The stock has a market capitalization of $6.65 billion, a price-to-earnings ratio of 121.02, a PEG ratio of 1.28 and a beta of 0.55. HealthEquity, Inc. has a 52 week low of $53.58 and a 52 week high of $84.49. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The firm has a 50 day moving average of $80.46 and a 200 day moving average of $74.77.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The firm had revenue of $262.39 million during the quarter, compared to analyst estimates of $258.56 million. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the transaction, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at approximately $3,917,904.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Delano Ladd sold 2,558 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the transaction, the executive vice president now owns 47,438 shares in the company, valued at approximately $3,917,904.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the sale, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 68,823 shares of company stock worth $5,482,975. Insiders own 2.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. JMP Securities assumed coverage on shares of HealthEquity in a research note on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price objective for the company. Royal Bank of Canada lifted their price target on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 20th. Barclays boosted their price objective on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research note on Friday, February 23rd. Bank of America raised their price objective on HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Finally, KeyCorp boosted their target price on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, March 22nd. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and a consensus price target of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.